Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple SclerosisTim Spelman, Jan Lycke, Jan Hillert et al.|JAMA Neurology|2021Cited by 237
The Danish Multiple Sclerosis RegistryMelinda Magyari, Nils Koch‐Henriksen, Hanna Joensen et al.|Brain and Behavior|2020Cited by 92
Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide studyPer Soelberg Sørensen, Melinda Magyari, Finn Sellebjerg et al.|Multiple Sclerosis and Related Disorders|2022Cited by 42
Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort studyLuigi Pontieri, Melinda Magyari, Morten Blinkenberg et al.|European Journal of Neurology|2021Cited by 29
Changes in prognosis of the Danish multiple sclerosis population over timeMelinda Magyari, Nils Koch‐Henriksen, Hanna Joensen et al.|Multiple Sclerosis Journal|2022Cited by 21